Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Ad26.COV2.S Emergency use authorization Experimental Vaccine Jun/22/2022 10 1
Colchicine Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/02/2022 20 5
ChAdOx1 nCoV-19 Emergency use authorization Experimental Vaccine Jan/04/2022 16 1
Azithromycin Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/26/2021 19 10
E-3G9 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/27/2021 1 0
E-3B1 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/27/2021 1 0
A-2F1 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/27/2021 1 0
A-2H4 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/27/2021 1 0
A-1H4 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/27/2021 1 0
Antihistamines Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/16/2021 1 0